AR227293A1 - Procedimiento para preparar imidazo(1,5a)(1,4)diazepin-3-carboxilatos de metilo,etilo e isopropilo - Google Patents

Procedimiento para preparar imidazo(1,5a)(1,4)diazepin-3-carboxilatos de metilo,etilo e isopropilo

Info

Publication number
AR227293A1
AR227293A1 AR282769A AR28276980A AR227293A1 AR 227293 A1 AR227293 A1 AR 227293A1 AR 282769 A AR282769 A AR 282769A AR 28276980 A AR28276980 A AR 28276980A AR 227293 A1 AR227293 A1 AR 227293A1
Authority
AR
Argentina
Prior art keywords
diazepin
carboxylates
isopropyl
ethyl
methyl
Prior art date
Application number
AR282769A
Other languages
English (en)
Spanish (es)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27509256&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR227293(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of AR227293A1 publication Critical patent/AR227293A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/241,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26Two oxygen atoms, e.g. isatoic anhydride
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/42Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms with nitro or nitroso radicals directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AR282769A 1979-10-04 1980-10-03 Procedimiento para preparar imidazo(1,5a)(1,4)diazepin-3-carboxilatos de metilo,etilo e isopropilo AR227293A1 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CH897179 1979-10-04
CH897279 1979-10-04
CH1066479 1979-11-30
CH1066579 1979-11-30
CH571680 1980-07-25

Publications (1)

Publication Number Publication Date
AR227293A1 true AR227293A1 (es) 1982-10-15

Family

ID=27509256

Family Applications (1)

Application Number Title Priority Date Filing Date
AR282769A AR227293A1 (es) 1979-10-04 1980-10-03 Procedimiento para preparar imidazo(1,5a)(1,4)diazepin-3-carboxilatos de metilo,etilo e isopropilo

Country Status (23)

Country Link
US (10) US4316839A (ko)
EP (1) EP0027214B1 (ko)
JP (1) JPH01156968A (ko)
AR (1) AR227293A1 (ko)
AU (1) AU533641B2 (ko)
BR (1) BR8006404A (ko)
CA (1) CA1143728A (ko)
DE (1) DE3067868D1 (ko)
DK (1) DK168094B1 (ko)
FI (1) FI73683C (ko)
GB (1) GB2060632B (ko)
GR (1) GR70772B (ko)
HU (1) HU182675B (ko)
IE (1) IE50318B1 (ko)
IL (1) IL61160A (ko)
LU (1) LU88298I2 (ko)
MC (1) MC1355A1 (ko)
NL (1) NL930056I2 (ko)
NO (1) NO155774C (ko)
NZ (1) NZ195071A (ko)
PH (1) PH16607A (ko)
PT (1) PT71874B (ko)
ZW (1) ZW21580A1 (ko)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1143728A (en) * 1979-10-04 1983-03-29 Max Gerecke Imidazodiazepine derivatives
CA1184175A (en) * 1981-02-27 1985-03-19 Walter Hunkeler Imidazodiazepines
CA1174673A (en) * 1981-02-27 1984-09-18 Walter Hunkeler Imidazodiazepines
CA1185602A (en) * 1981-02-27 1985-04-16 Emilio Kyburz Imidazodiazepines
US4352817A (en) * 1981-02-27 1982-10-05 Hoffmann-La Roche Inc. Imidazo-diazepines and their use
CA1173441A (en) * 1981-02-27 1984-08-28 Hoffmann-La Roche Limited Imidazodiazepines
MC1528A1 (fr) * 1982-07-21 1984-04-13 Hoffmann La Roche Imidazobenzodiazepines
DK151808C (da) * 1982-11-16 1988-06-20 Ferrosan As Analogifremgangsmaade til fremstilling af oxadiazolylimidazo-oe1,4aa-benzodiazepinderivater
US4723003A (en) * 1983-05-18 1988-02-02 Hoechst-Roussel Pharmaceuticals Inc. Benzopyrrolobenzodiazepines and quinobenzodiazepines
CS249148B2 (en) * 1984-01-19 1987-03-12 Hoffmann La Roche Method of new imidazodiazepine's derivatives production
AU587802B2 (en) * 1985-03-08 1989-08-31 Ferrosan A/S Novel oxadiazolyl imidazobenzodiazepine derivatives and methods of preparing such compounds
US4622321A (en) * 1985-05-17 1986-11-11 As Ferrosan Oxadiazolylimidazobenzodiazepine, compositions, and method
US4745112A (en) * 1985-05-17 1988-05-17 A/S Ferrosan Oxadiazolylimidazobenzodiazepine, compositions, and method III
DK174086D0 (da) * 1986-04-16 1986-04-16 Ferrosan As Nye benzodiazepinderivater samt fremgangsmaade til fremstilling af samme
FI880814A (fi) * 1987-03-10 1988-09-11 Hoffmann La Roche Imidazodiazepin-derivat.
GB8720414D0 (en) * 1987-08-28 1987-10-07 Roussel Lab Ltd Chemical compounds
US5096695A (en) * 1988-08-05 1992-03-17 Hoffmann-Laroche Inc. Radioiodine benzodiazepines as brain imaging agents
ATE82851T1 (de) * 1988-08-05 1992-12-15 Hoffmann La Roche Radioaktiv markierte benzodiazepinderivate.
CA1327572C (en) * 1988-08-31 1994-03-08 F. Hoffmann-La Roche Ag Imidazodiazepine derivatives
GB8909700D0 (en) * 1989-04-27 1989-06-14 Roussel Lab Ltd Chemical compounds
CA2015336A1 (en) * 1989-05-19 1990-11-19 F. Hoffmann-La Roche Ag Imidazodiazepines for the treatment of neurological symptoms
FR2660310B1 (fr) * 1990-03-27 1992-06-05 Adir Nouveaux derives de la 4h-pyrrolo[1,2a] thieno[2,3-f] diazepine[1,4], leur procede de preparation et les compositions pharmaceutiques les renfermant.
US5371080A (en) * 1990-06-22 1994-12-06 Novo Nordisk A/S Imidazoquinazoline compounds and their use
US5276028A (en) * 1990-06-22 1994-01-04 Nordisk A/S Imidazoquinoxaline compounds
TW201311B (ko) * 1991-06-17 1993-03-01 Hoffmann La Roche
US5663166A (en) * 1991-10-18 1997-09-02 Genentech, Inc. Nonpeptidyl integrin inhibitors having specificity for the GPIIb IIIa receptor
US5250679A (en) * 1991-10-18 1993-10-05 Genentech, Inc. Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptor
US5438035A (en) * 1994-06-24 1995-08-01 American Cyanamid Company Methods for controlling undesirable plant species with benzodiazepine compounds
TW349100B (en) * 1994-11-11 1999-01-01 Hoffmann La Roche Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines
US5670640A (en) 1996-02-02 1997-09-23 Hoffmann-La Roche Inc. Process for the manufacture of imidazodiazepine derivatives
GB2328940B (en) * 1997-09-05 1999-12-08 Dong Kook Pharm Co Ltd A process for preparing benzodiazepine derivatives
CA2548917C (en) 2003-12-11 2014-09-23 Sepracor Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
CA2581918A1 (en) 2004-10-12 2006-04-20 Henner Knust Imidazo(1,5-a)triazolo(1,5-d) benzodiazepine deratives for the treatment of cognitive disorders
MX2007004640A (es) 2004-10-20 2007-06-08 Hoffmann La Roche Derivados de benzodiazepina sustituidos con halogeno.
EP1805184B1 (en) 2004-10-20 2013-01-09 F. Hoffmann-La Roche AG Imidazo-benzodiazepine derivatives
MX2007007115A (es) 2004-12-14 2007-07-11 Hoffmann La Roche Imidazo-benzodiazepinas tetraciclicas como moduladoras del receptor del acido gamma-aminobutirico (gaba).
WO2007018660A2 (en) * 2005-05-16 2007-02-15 Wisys Technology Foundation, Inc. Gabaergic imidazobenzodiazepine derivatives to treat memory deficits
US7678363B2 (en) 2005-08-26 2010-03-16 Braincells Inc Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
US20070112017A1 (en) * 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
EP1991212A1 (en) * 2006-03-08 2008-11-19 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US20100216734A1 (en) * 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
MX2008014320A (es) 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
JP2010502722A (ja) * 2006-09-08 2010-01-28 ブレインセルス,インコーポレイティド 4−アシルアミノピリジン誘導体を含む組み合わせ
AU2007299920A1 (en) * 2006-09-19 2008-03-27 Braincells, Inc. PPAR Mediated Modulation of Neurogenesis
US20090054412A1 (en) * 2007-08-20 2009-02-26 John Alan Kemp Treatment of Sleep Disorders
EP2190435B1 (en) * 2007-08-20 2018-05-30 Evotec International GmbH Treatment of sleep disorders
US20090270373A1 (en) * 2008-04-11 2009-10-29 Cypress Biosciences, Inc. Treatment of down syndrom with benzodiazepine receptor antagonists
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
GB0917612D0 (en) * 2009-10-08 2009-11-25 Ge Healthcare Ltd In vivo imaging agents
ES2702848T3 (es) 2011-02-23 2019-03-05 Coeruleus Ltd Complejos de flumazenil, composiciones que los comprenden y usos de los mismos
CN102267999B (zh) * 2011-07-15 2013-05-29 海南美兰史克制药有限公司 一种氟马西尼化合物及其制法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3933794A (en) * 1971-08-04 1976-01-20 The Upjohn Company 2-(2-Alkynylamino)-3H-1,4-benzodiazepines
US4031079A (en) * 1975-09-22 1977-06-21 Mcneil Laboratories, Incorporated Intermediates for 2-aminobenzodiazepine-5-ones
US4002610A (en) * 1975-09-22 1977-01-11 Mcneil Laboratories, Incorporated 2-Aminobenzodiazepine-5-ones
US4118386A (en) * 1977-04-04 1978-10-03 Hoffmann-La Roche Inc. Synthesis of imidazo[1,5-a]diazepine-3-carboxylates
CA1143728A (en) * 1979-10-04 1983-03-29 Max Gerecke Imidazodiazepine derivatives
ZA806016B (en) * 1979-10-04 1981-09-30 Hoffmann La Roche Imidazodiazepine derivatives
JPH089074B2 (ja) * 1987-07-02 1996-01-31 株式会社アマダ タレツトパンチプレス

Also Published As

Publication number Publication date
NL930056I1 (nl) 1993-09-01
AU6278280A (en) 1981-04-09
US4346033A (en) 1982-08-24
IE802056L (en) 1981-04-04
NZ195071A (en) 1984-08-24
IE50318B1 (en) 1986-04-02
NL930056I2 (nl) 1993-11-16
US4363762A (en) 1982-12-14
EP0027214B1 (de) 1984-05-16
NO155774B (no) 1987-02-16
GB2060632A (en) 1981-05-07
NO802946L (no) 1981-04-06
IL61160A0 (en) 1980-11-30
JPH01156968A (ja) 1989-06-20
BR8006404A (pt) 1981-04-14
DE3067868D1 (en) 1984-06-20
CA1143728A (en) 1983-03-29
DK168094B1 (da) 1994-02-07
DK391280A (da) 1981-04-05
ZW21580A1 (en) 1981-04-29
LU88298I2 (fr) 1994-05-04
MC1355A1 (fr) 1981-08-10
EP0027214A1 (de) 1981-04-22
FI73683B (fi) 1987-07-31
US4346035A (en) 1982-08-24
PT71874B (en) 1982-03-31
US4346031A (en) 1982-08-24
AU533641B2 (en) 1983-12-01
JPH0369913B2 (ko) 1991-11-05
PH16607A (en) 1983-11-24
US4346034A (en) 1982-08-24
FI73683C (fi) 1987-11-09
IL61160A (en) 1983-07-31
GR70772B (ko) 1983-03-22
GB2060632B (en) 1983-11-02
HU182675B (en) 1984-02-28
NO155774C (no) 1987-05-27
US4346036A (en) 1982-08-24
FI803135L (fi) 1981-04-05
US4359420A (en) 1982-11-16
US4346032A (en) 1982-08-24
PT71874A (en) 1980-11-01
US4346030A (en) 1982-08-24
US4316839A (en) 1982-02-23

Similar Documents

Publication Publication Date Title
AR227293A1 (es) Procedimiento para preparar imidazo(1,5a)(1,4)diazepin-3-carboxilatos de metilo,etilo e isopropilo
AR230989A1 (es) Procedimiento para preparar acilureidoalquil-bencen-sulfonilureas
MX154095A (es) Procedimiento para preparar polieteres sililados
ES492255A0 (es) Procedimiento para preparar aroilimidazol-2-onas
ES557118A0 (es) Procedimiento para preparar (1,2,4) triazolo (1,5-c) quinazolinas
AR231635A1 (es) Procedimiento para preparar acidos azabiciclicos
MX6816E (es) Procedimiento para preparar quinolonas
ES493139A0 (es) Procedimiento para preparar derivados de indolizina
RO81115A (ro) Procedeu pentru prepararea unor d-6-n-propilergoline
AR227284A1 (es) Procedimiento para preparar antraceno-9,10-bis-carbonil-hidrazonas
MX158200A (es) Procedimiento para preparar dimetileter
MX7642E (es) Procedimiento para preparar la 1-ciclo-hexenilmentil-2-cloroetil pirrolidina
MX6141E (es) Procedimiento para preparar acil-ureas
AR226634A1 (es) Procedimiento para preparar cligolaldehido
MX6024E (es) Procedimiento para preparar 2-cloro-4-hidroximetil-tiazoles-5-substituidos
MX6405E (es) Procedimiento para preparar tiazolilideno-oxo-propionitrilos
ES525186A0 (es) Procedimiento para preparar nuevas imidazo-(1,2-a)-pirimidinas
AR231447A1 (es) Procedimiento para preparar derivados de 4,5-dihidro-imidazo 1,2-a-quinazolin-2 1h-ona
ES538156A0 (es) Procedimiento para preparar derivados de 2(1h)-piridona
ES488026A0 (es) Procedimiento para preparar (n-cianoimido) carbonatos disus-tituidos
ES491153A0 (es) Procedimiento de preparar derivados pirrolo(1,2-a)pirimidi- nicos
ES496518A0 (es) Procedimiento para preparar bencil-oximeteres trisustituidos
AR227962A1 (es) Procedimiento para preparar antibioticos ll-bo1208alpha y ll-bo1208beta
MX6219E (es) Procedimiento para preparar derivados de 1,1'-bifenil-2-il-alquilamina
MX6271E (es) Procedimiento para preparar n-ciandalquil haloacetamidas